These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37166303)

  • 1. Individual, Social, and Environmental Factors Associated with Different Patterns of Stimulant Use: A Cross-Sectional Study from Five European Countries.
    Rosenkranz M; O'Donnell A; Martens MS; Zurhold H; Degkwitz P; Liebregts N; Barták M; Rowicka M; Verthein U
    Eur Addict Res; 2023; 29(3):182-193. PubMed ID: 37166303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study.
    Martens MS; Zurhold H; Rosenkranz M; O'Donnell A; Addison M; Spencer L; McGovern W; Gabrhelík R; Petruželka B; Rowicka M; Liebregts N; Degkwitz P; Kaner E; Verthein U
    Harm Reduct J; 2020 Jan; 17(1):8. PubMed ID: 31931819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine-Type Stimulant Dependence and Association with Concurrent Use of Cocaine, Alcohol, and Cannabis: A Cross-Sectional Study.
    Berndt S; Rosenkranz M; Martens MS; Verthein U
    Eur Addict Res; 2022; 28(2):113-121. PubMed ID: 34788752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding pathways to stimulant use: a mixed-methods examination of the individual, social and cultural factors shaping illicit stimulant use across Europe (ATTUNE): study protocol.
    Rosenkranz M; O'Donnell A; Verthein U; Zurhold H; Addison M; Liebregts N; Rowicka M; Barták M; Petruželka B; Kaner EF; Martens MS
    BMJ Open; 2019 Aug; 9(8):e029476. PubMed ID: 31401601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance Use, Health, and Adverse Life Events amongst Amphetamine-Type Stimulant Users in North East England: A Cross-Sectional Study.
    Adams EA; Spencer L; Addison M; McGovern W; Alderson H; Adley M; McGovern R; Gilvarry E; Kaner E; O'Donnell A
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-border Activities Associated With Pattern of Amphetamine-type Stimulants Usage Among Drug Users in Southwest of China.
    Zhang M; Li J; Fan J; Feng D; Li Q; Tang S; Li J
    Inquiry; 2023; 60():469580231206608. PubMed ID: 37902428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use trajectories of amphetamine-type stimulants (ATS) in Shanghai, China.
    Du J; Sun H; Huang D; Jiang H; Zhong N; Xu D; Zhao Y; Lin S; Wang W; Du Z; Zhao M; Hser YI
    Drug Alcohol Depend; 2014 Oct; 143():44-50. PubMed ID: 25081602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study.
    Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J
    Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Look west for Australian evidence of the relationship between amphetamine-type stimulant prescribing and meth/amphetamine use.
    Whitely M; Allsop S
    Drug Alcohol Rev; 2020 Jul; 39(5):519-524. PubMed ID: 32314469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.
    Harada T; Tsutomi H; Mori R; Wilson DB
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011315. PubMed ID: 30577083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of drug use and depressive symptoms among amphetamine type stimulants users in Beijing and Guangdong province, China.
    Bao YP; Qiu Y; Yan SY; Jia ZJ; Li SX; Lian Z; Mu Y; Liu ZM
    PLoS One; 2013; 8(4):e60544. PubMed ID: 23585838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.
    Harada T; Tsutomi H; Mori R; Wilson DB
    Campbell Syst Rev; 2019 Jun; 15(1-2):e1026. PubMed ID: 37131466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A voxel-based morphometry study of young occasional users of amphetamine-type stimulants and cocaine.
    Mackey S; Stewart JL; Connolly CG; Tapert SF; Paulus MP
    Drug Alcohol Depend; 2014 Feb; 135():104-11. PubMed ID: 24342420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does chronic use of amphetamine-type stimulants impair interference control? - A meta-analysis.
    Opitz A; Petasch MS; Klappauf R; Kirschgens J; Hinz J; Dittmann L; Dathe AS; Quednow BB; Beste C; Stock AK
    Neurosci Biobehav Rev; 2023 Mar; 146():105020. PubMed ID: 36581170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysis.
    Vu NT; Maher L; Zablotska I
    J Int AIDS Soc; 2015; 18(1):19273. PubMed ID: 25609214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.
    Indave BI; Sordo L; Bravo MJ; Sarasa-Renedo A; Fernández-Balbuena S; De la Fuente L; Sonego M; Barrio G
    Drug Alcohol Rev; 2018 Jan; 37(1):56-69. PubMed ID: 28485090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use during the COVID-19 pandemic: What is really happening?
    Mellos E; Paparrigopoulos T
    Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use Motives of Patients with Amphetamine-Type Stimulants Use Disorder and Attention-Deficit/Hyperactivity Disorder.
    Thurn D; Riedner A; Wolstein J
    Eur Addict Res; 2020; 26(4-5):254-262. PubMed ID: 32564027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of amphetamine-type stimulant use among transgender women in Cambodia.
    Mburu G; Tuot S; Mun P; Chhoun P; Chann N; Yi S
    Int J Drug Policy; 2019 Dec; 74():136-143. PubMed ID: 31590089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Barriers Associated with Amphetamine-Type Stimulant (ATS) Use in Malaysia.
    Singh D; Narayanan S; Shanmugam T; Vicknasingam B
    J Psychoactive Drugs; 2022; 54(1):25-33. PubMed ID: 33749541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.